title: Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment.
authors.affiliation: Infectious Diseases Department, IRCCS Ospedale San Raffaele, Milan, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Spagnuolo
authors.forename: Deborah
authors.initials: D
authors.lastname: Cocorullo
authors.forename: Laura
authors.initials: L
authors.lastname: Galli
authors.forename: Alba
authors.initials: A
authors.lastname: Bigoloni
authors.forename: Andrea
authors.initials: A
authors.lastname: Galli
authors.forename: Alessandro
authors.initials: A
authors.lastname: Rubinacci
authors.forename: Giovanna
authors.initials: G
authors.lastname: Mignogna
authors.forename: Alessia
authors.initials: A
authors.lastname: Carbone
authors.forename: Adriano
authors.initials: A
authors.lastname: Lazzarin
authors.forename: Antonella
authors.initials: A
authors.lastname: Castagna
mesh_terms: D000328:Adult; D000368:Aged; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000097:blood*; D010949:Plasma / Q000737:chemistry; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D044966:Anti-Retroviral Agents; D015415:Biomarkers; D015675:Osteocalcin; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23
keywords: biomarkers; bone; comorbidities; hormones